Clinical Trials
1.1k
Active:38
Completed:221
Trial Phases
5 Phases
Phase 1:15
Phase 2:113
Phase 3:135
+2 more phases
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (717 trials with phase data)• Click on a phase to view related trials
Not Applicable
411 (57.3%)Phase 3
135 (18.8%)Phase 2
113 (15.8%)Phase 4
26 (3.6%)Phase 1
15 (2.1%)phase_2_3
13 (1.8%)phase_1_2
4 (0.6%)Systemic and Tumor Immune Response During Pelvic (chemo)Radiation And/or Brachytherapy for Cervical Cancer
Not yet recruiting
- Conditions
- Cervical Carcinoma
- First Posted Date
- 2025-02-03
- Last Posted Date
- 2025-02-06
- Lead Sponsor
- Tata Memorial Hospital
- Target Recruit Count
- 110
- Registration Number
- NCT06804135
Spatially Fractionated Radiation Treatment for Gynaecological Cancers
Not Applicable
Not yet recruiting
- Conditions
- Cervical CancerGynecologic CancerRecurrent Cancer
- First Posted Date
- 2024-10-16
- Last Posted Date
- 2024-10-16
- Lead Sponsor
- Tata Memorial Hospital
- Target Recruit Count
- 20
- Registration Number
- NCT06644846
To Check Safety of Ayurvedic Oral Cannabis in Breast and Head and Neck Cancer
- First Posted Date
- 2023-08-01
- Last Posted Date
- 2025-04-11
- Lead Sponsor
- Tata Memorial Hospital
- Target Recruit Count
- 12
- Registration Number
- NCT05969314
- Locations
- 🇮🇳
Tata Memorial Center, Mumbai, Maharashtra, India
🇮🇳Tata Memorial Hospital, Mumbai, Maharastra, India
Sentinel Node Biopsy in Early Oral Cancers a Tertiary Cancer Centre Experience
Not Applicable
Completed
- Conditions
- Oral Cavity Squamous Cell Carcinoma
- First Posted Date
- 2023-07-18
- Last Posted Date
- 2024-10-30
- Lead Sponsor
- Tata Memorial Hospital
- Target Recruit Count
- 115
- Registration Number
- NCT05950737
- Locations
- 🇮🇳
Tata Memorial Hospital, Mumbai, Maharashtra, India
An Adequate Cost Effective Follow Up Protocol For Bone and Soft Tissue Sarcomas
Completed
- Conditions
- Sarcomas
- First Posted Date
- 2023-04-25
- Last Posted Date
- 2023-04-25
- Lead Sponsor
- Tata Memorial Hospital
- Target Recruit Count
- 500
- Registration Number
- NCT05827458
- Locations
- 🇮🇳
Tata Memorial Hospital, Mumbai, Maharashtra, India
- Prev
- 1
- 2
- 3
- 4
- 5
- 18
- Next
News
India's Indigenous CAR T-Cell Therapy Revolutionizes Cancer Treatment at One-Tenth Global Cost
India has successfully developed NexCAR19, its first indigenous CAR T-cell therapy for blood cancers, priced at approximately Rs 40 lakh ($50,000) compared to $400,000 in the United States.